SARS-CoV-2 infection and recovery in children: Distinct T cell responses in MIS-C compared to COVID-19

J Exp Med. 2023 Aug 7;220(8):e20221518. doi: 10.1084/jem.20221518. Epub 2023 May 3.

Abstract

SARS-CoV-2 infection for most children results in mild or minimal symptoms, though in rare cases severe disease can develop, including a multisystem inflammatory syndrome (MIS-C) with myocarditis. Here, we present longitudinal profiling of immune responses during acute disease and following recovery in children who developed MIS-C, relative to children who experienced more typical symptoms of COVID-19. T cells in acute MIS-C exhibited transient signatures of activation, inflammation, and tissue residency which correlated with cardiac disease severity, while T cells in acute COVID-19 upregulated markers of follicular helper T cells for promoting antibody production. The resultant memory immune response in recovery showed increased frequencies of virus-specific memory T cells with pro-inflammatory functions in children with prior MIS-C compared to COVID-19 while both cohorts generated comparable antibody responses. Together our results reveal distinct effector and memory T cell responses in pediatric SARS-CoV-2 infection delineated by clinical syndrome, and a potential role for tissue-derived T cells in the immune pathology of systemic disease.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • COVID-19*
  • Child
  • Humans
  • Inflammation
  • SARS-CoV-2
  • Severity of Illness Index

Supplementary concepts

  • pediatric multisystem inflammatory disease, COVID-19 related